Actively Recruiting
A Retrospective Survey of the Time Course and Nature of the Experience of Initiating Biologic Treatment for People with Severe Asthma
Led by Royal Devon and Exeter NHS Foundation Trust · Updated on 2025-06-27
400
Participants Needed
1
Research Sites
8 weeks
Total Duration
On this page
Sponsors
R
Royal Devon and Exeter NHS Foundation Trust
Lead Sponsor
U
University of Plymouth
Collaborating Sponsor
AI-Summary
What this Trial Is About
Severe asthma is a condition marked by respiratory symptoms like breathlessness, wheezing, and asthma attacks, along with non-respiratory symptoms that affect patients' social, work, and personal lives, sometimes causing depression and isolation. This research aims to understand patients' experiences with biologic treatments for severe asthma, focusing on how responses vary, including the speed of response, side effects, and broader impacts on daily life. The study is observational and designed with input from patients to ensure the survey reflects their perspectives. Participants will complete a 23-item survey about their experiences with biologic treatments for severe asthma, especially the time course and nature of their response. The survey will gather information on treatment changes, side effects, demographics, and medication use. Patients must have received biologic treatment for between 6 and 18 months. Surveys are completed online independently, in the participant's native language, with recruitment and progress monitored by research staff. Participants will provide information about their experiences without assistance, completing the survey after consenting. Researchers will analyze data to describe response patterns, side effects, and satisfaction with treatment among 400 patients. The main outcome is the detailed patient experience survey reflecting their perception of biologic treatment effects over 6 to 18 months. This study helps identify factors influencing treatment responses and may guide future research.
CONDITIONS
Brief Title
Experience of Biologic Treatments for Severe Asthma: a Survey
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Receiving a biologic treatment for at least 6 months
- Not on the biologic treatment for longer than 18 months
- Able and willing to provide consent to use their data
- Adults aged 18 years or older
You will not qualify if you...
- Unwilling or unable to provide consent to use their data
- Patients who have switched biologic treatments
- Patients with other significant conditions affecting respiratory symptoms, such as lung cancer, heart failure, or severe COPD
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person) to confirm eligibility and obtain consent
Duration - One-time activity
Participants complete a survey about their experiences with biologic treatments for severe asthma, including changes noticed, side effects, and satisfaction.
1 survey completion visit (online or in-person)
Trial Site Locations
Total: 1 location
1
Royal Devon University Healthcare NHS Foundation Trust
Exeter, Devon, United Kingdom, EX2 5DW
Actively Recruiting
Research Team
J
Joseph Lanario, PhD
A
Alison Kerridge, PhD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here